Mathias Hothum

Mathias Hothum is managing director of Dievini GmbH & Co. KG, advisors in health sciences. Dievini manages the biotech investments of SAP co-founder Dietmar Hopp. He received his Diploma degree in Economics from the University of Mannheim and his doctorate from the University of Magdeburg. For the past 20 years, he has gained experience as a health economist in the sectors healthcare, health services and life sciences. He specializes in pricing, reimbursement and in the evaluation of medium-sized companies as well as of publicly owned/market-listed companies. He is the owner and founder of HMM-Consulting. Furthermore, Mathias Hothum serves as a member of the boards of Apogenix GmbH, Cytonet GmbH, Joimax GmbH and Novaliq GmbH. © 2002-2013 CureVac GmbH the RNA people . Disclaimer . Imprint